BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 921074)

  • 1. Carcinoma of the esophagus.
    Hutchinson WB; Hutchinson WB
    Am Surg; 1977 Nov; 43(11):709-14. PubMed ID: 921074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.
    Laterza E; Mosciaro O; Urso US; Inaspettato G; Cordiano C
    Hepatogastroenterology; 1994 Jun; 41(3):278-82. PubMed ID: 7959554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal carcinoma. Improved quality of survival with resection.
    Bluett MK; Sawyers JL; Healy D
    Am Surg; 1987 Mar; 53(3):126-32. PubMed ID: 2435199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resectional operations and long-term results in carcinoma of the esophagus.
    Gatzinsky P; Berglin E; Dernevik L; Larsson I; William-Olsson G
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):71-6. PubMed ID: 3965818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of carcinoma of the proximal esophagus.
    Chakkaphak S; Krishnasamy S; Walker SJ; Ferguson MK; Skinner DB; Little AG
    Surg Gynecol Obstet; 1989 Apr; 168(4):307-10. PubMed ID: 2928905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
    Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
    Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of neoadjuvant radiochemotherapy in squamous carcinoma of the thoracic esophagus].
    Pedrazzani C; Laterza E; Pasini F; Grandinetti A; Bernini M; Giacopuzzi S; Zerman G; Tasselli S; Ruzzenente A; De Manzoni G
    Minerva Chir; 2005 Feb; 60(1):11-6. PubMed ID: 15902048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Self-expanding metal prosthesis as palliative treatment in esophageal cancer].
    Güitrón A; Adalid R; Barinagarrementería R; Mena G; Gutiérrez JA; Nares J
    Rev Gastroenterol Mex; 1998; 63(4):198-203. PubMed ID: 10319669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastro-esophageal isoperistaltic bypass in the palliation of irresectable thoracic esophageal cancer.
    Alcantara PS; Spencer-Netto FA; Silva-Júnior JF; Soares LA; Pollara WM; Bevilacqua RG
    Int Surg; 1997; 82(3):249-53. PubMed ID: 9372368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
    Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
    Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
    Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
    Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution.
    Ruol A; Castoro C; Portale G; Cavallin F; Sileni VC; Cagol M; Alfieri R; Corti L; Boso C; Zaninotto G; Peracchia A; Ancona E
    Arch Surg; 2009 Mar; 144(3):247-54; discussion 254. PubMed ID: 19289664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative radiotherapy for carcinoma of the esophagus.
    Launois B; Delarue D; Campion JP; Kerbaol M
    Surg Gynecol Obstet; 1981 Nov; 153(5):690-2. PubMed ID: 6794167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
    Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment in esophageal cancer].
    Schumpelick V; Fass J; Truong S; Dreuw B; Treutner KH
    Chirurg; 1992 Sep; 63(9):715-21. PubMed ID: 1382923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
    Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
    Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
    Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
    Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.